Treatment of Leber Congenital Amaurosis Due toRPE65Mutations by Ocular Subretinal Injection of Adeno-Associated Virus Gene Vector: Short-Term Results of a Phase I Trial

Human Gene Therapy - United States
doi 10.1089/hum.2008.107
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Mary Ann Liebert Inc

Related search

Leber Congenital Amaurosis

2020English

Potential Long-Term Inhibition of Ocular Neovascularisation by Recombinant Adeno-Associated Virus-Mediated Secretion Gene Therapy

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2002English

Structure of Adeno-Associated Virus Serotype 8, a Gene Therapy Vector

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2007English

Hypomorphic Mutations Identified in the Candidate Leber Congenital Amaurosis Gene CLUAP1

Genetics in Medicine
MedicineGenetics
2016English

Leber Congenital Amaurosis RPE65: 7 Years Follow Up

Gaceta Medica de Mexico
Medicine
2019English

Differential Proteomics and Functional Research Following Gene Therapy in a Mouse Model of Leber Congenital Amaurosis

PLoS ONE
Multidisciplinary
2012English

Mutation Screen of the TUB Gene in Patients With Retinitis Pigmentosa and Leber Congenital Amaurosis

Experimental Eye Research
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2006English

The Phenotype of Leber Congenital Amaurosis in Patients With AIPL1 Mutations

Archives of Ophthalmology
2004English

Pharmacological and rAAV Gene Therapy Rescue of Visual Functions in a Blind Mouse Model of Leber Congenital Amaurosis

PLoS Medicine
BiochemistryBiotechnologyMolecular BiologyCell BiologyMedicine
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy